BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stewart LK, Kline JA. Fibrinolytics for the treatment of pulmonary embolism. Transl Res 2020;225:82-94. [PMID: 32434005 DOI: 10.1016/j.trsl.2020.05.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Zuo Z, Yue J, Dong BR, Wu T, Liu GJ, Hao Q. Thrombolytic therapy for pulmonary embolism. Cochrane Database Syst Rev 2021;4:CD004437. [PMID: 33857326 DOI: 10.1002/14651858.CD004437.pub6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Zhang Z, Xi L, Zhang S, Zhang Y, Fan G, Tao X, Gao Q, Xie W, Yang P, Zhai Z, Wang C. Tenecteplase in Pulmonary Embolism Patients: A Meta-Analysis and Systematic Review. Front Med 2022;9:860565. [DOI: 10.3389/fmed.2022.860565] [Reference Citation Analysis]
3 Disharoon D, Trewyn BG, Herson PS, Marr DWM, Neeves KB. Breaking the fibrinolytic speed limit with microwheel co-delivery of tissue plasminogen activator and plasminogen. J Thromb Haemost 2021. [PMID: 34882946 DOI: 10.1111/jth.15617] [Reference Citation Analysis]
4 Capanegro J, Quinn E, Arndt M, Sherard D. Successful removal of a Life-threatening PE using the INARI flow triever device. Radiol Case Rep 2021;16:1878-81. [PMID: 34113410 DOI: 10.1016/j.radcr.2021.04.045] [Reference Citation Analysis]